Adjuvant EGFR-TKI therapy in resected EGFR-mutation positive non-small cell lung cancer: A real-world study

BACKGROUND: Although several clinical studies have laid the foundation for the adjuvant application of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), some questions remain unresolved. This real-world study aimed to address questions such as the effect of adjuvant chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun-Feng, Sun, Xu-Sheng, Yin, Jin-Huan, Xu, Xi-E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040744/
https://www.ncbi.nlm.nih.gov/pubmed/36994198
http://dx.doi.org/10.3389/fonc.2023.1132854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040744/
https://www.ncbi.nlm.nih.gov/pubmed/36994198
http://dx.doi.org/10.3389/fonc.2023.1132854

Ejemplares similares